AI-generated summary
The authors report a pilot study of 12 patients with papillary loss between teeth, split into a hemolaser therapy group and a red laser only control group of six each. They describe papillary height and area reductions, better Modified Papilla Index scores, and lower discomfort and oral health impact over 90 to 180 days, which they interpret as hemolaser therapy being effective for reducing interdental black spaces.
- Participants
- 12
- Who or what was studied
- Twelve consecutive patients with papillary loss, divided into a HLT group (n = 6) and a control group (n = 6)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a small pilot study with only six patients per group and a short follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Pilot study, Control group, Laser, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.